Microenvironment targets in KRAS-mutated metastatic colorectal cancer

被引：0
|
作者：
Marchio, Serena [1 ]
Bartolini, Alice [1 ]
Cardaci, Sabrina [2 ]
Soster, Marco [2 ]
Corti, Giorgio [1 ]
Lamba, Simona [1 ]
Bussolino, Federico [2 ]
Cora', Davide [1 ]
Nicolantonio, Federica D. [2 ]
机构：
[1] Inst Canc Res & Treatment, Candiolo, Italy
[2] Univ Turin, Candiolo, Italy
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1163
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1163
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Non-engineered T cells with specific anticancer effects in KRAS-mutated colorectal cancer
    Lim, Sunki
    Gho, Yujeong
    Kim, Seoyoung
    Kim, Min Ki
    Park, Jong Seob
    Lee, Wang Jun
    Lee, Young-Kwan
    Moon, Hyoun Jong
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer
    Shanmugam, Vijayalakshmi
    Ramanathan, Ramesh K.
    Lavender, Nicole A.
    Sinari, Shripad
    Chadha, Manpreet
    Liang, Winnie S.
    Kurdoglu, Ahmet
    Izatt, Tyler
    Christoforides, Alexis
    Benson, Hollie
    Phillips, Lori
    Baker, Angela
    Murray, Christopher
    Hostetter, Galen
    Von Hoff, Daniel D.
    Craig, David W.
    Carpten, John D.
    BMC MEDICAL GENOMICS, 2014, 7
  • [33] Avutometinib plus cetuximab after chemotherapy in patients with KRAS-mutated metastatic colorectal cancer: Results of phase 1 dose escalation.
    Gujarathi, Rushabh
    Polite, Blase N.
    Cursio, John
    Desgardin, Aurelie
    El-Naggar, Ryan
    Savaiano, Cindy
    Wherity, Katherine
    Shaik, Afnan
    Nambiar, Chetan
    Arndt, Nicole
    Serbas, Lianna
    Neerukonda, Anu Radha
    Liao, Chih-Yi
    Shergill, Ardaman
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 199 - 199
  • [34] MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers
    Choi, Yong Won
    Song, Young Soo
    Lee, Hyunwoo
    Yi, Kijong
    Kim, Young-Bae
    Suh, Kwang Wook
    Lee, Dakeun
    MEDICINE, 2016, 95 (15)
  • [35] Potential treatment target discovered for KRAS-mutated colon cancer
    不详
    COLORECTAL CANCER, 2012, 1 (02) : 100 - 100
  • [36] YB-1 activating cascades as potential targets in KRAS-mutated tumors
    Shayan Khozooei
    Soundaram Veerappan
    Mahmoud Toulany
    Strahlentherapie und Onkologie, 2023, 199 : 1110 - 1127
  • [37] YB-1 activating cascades as potential targets in KRAS-mutated tumors
    Khozooei, Shayan
    Veerappan, Soundaram
    Toulany, Mahmoud
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (12) : 1110 - 1127
  • [38] Differential mRNA Expression Distinguishes Serrated KRAS-Mutated Adenomas From Conventional KRAS-Mutated Adenomas of the Colon
    Cassidy, Michael R.
    O'Brien, Michael J.
    Yang, Shi
    Gillespie, Earl
    Stucchi, Arthur F.
    Becker, James M.
    GASTROENTEROLOGY, 2011, 140 (05) : S1059 - S1059
  • [39] Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
    Toda, Kosuke
    Nishikawa, Gen
    Iwamoto, Masayoshi
    Itatani, Yoshiro
    Takahashi, Ryo
    Sakai, Yoshiharu
    Kawada, Kenji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [40] Phase II study of linifanib in KRAS mutated metastatic refractory colorectal cancer
    Chan, E.
    Ayers, G. D.
    Goff, L.
    McClanahan, P.
    Holloway, M.
    Ciombor, K.
    Smith, S. J.
    Ancell, K.
    Cardin, D. B.
    Berlin, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S549 - S549
12345